MedEthix receives accolades at Healthcare Asia Pharma Awards for Endometriosis Women’s Health Masterclass

MedEthix Endometriosis Masterclass Recognized for Most Differentiated Service of the Year and Hospital

Partnership of the Year

Receiving the awards on behalf of MedEthix for Most Differentiated Service of the Year and the Hospital Partnership of the Year at the Healthcare Asia Pharma Awards 2025 are (from left to right) Marlon dela Merced, Group Business Unit Head; IanMedina, District Supervisor; Johanna Romero, Strategy Execution and Support Services Director; Macy Relosa, Corporate Communications Manager; Theresa Nallos, Senior District Manage

Philippine-based pharmaceutical company MedEthix Incorporated was recently recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass (MEM), a continuing medical
education program that aims to help address a condition that has caused significant suffering for many
women in the country.

The MedEthix Endometriosis Masterclass received two accolades, the Most Differentiated Service of the
Year and Hospital Partnership of the Year, at the Healthcare Asia Pharma awards ceremony in Kuala
Lumpur, Malaysia.

Advocating Better Women’s Health

Now in its third year of delivering value to sonologists, the MedEthix Endometriosis Masterclass (MEM)
continues to be a pioneering Continuing Medical Education (CME) program by MedEthix, in partnership
with the Rizal Medical Center’s (RMC) Department of Obstetrics and Gynecology, Section of Ultrasound
in Obstetrics and Gynecology. Compared to other CME programs, the MEM incorporates actual patients
into the learning experience, providing hands-on, real-world training.

“We’re truly honored to be recognized by Healthcare Asia. Since launching MedEthix’s Women’s Health
division in 2015, we have remained steadfast in improving reproductive health for Filipino women,
especially for underserved conditions like endometriosis. This really fueled our commitment to create a
program for better endometriosis treatment that would help both the medical community and patients
alike,” shared Monaliza Salian, President and CEO of MedEthix Inc.

Endometriosis significantly impacts quality of life, primarily through chronic pelvic pain and infertility.
Alarmingly, according to published literature, proper diagnosis takes an average of 6.5 years, mainly due
to misconceptions that chronic pelvic pain is just normal dysmenorrhea. Many patients seek help only
when pain becomes severe or infertility becomes a concern. In the Philippines, while obstetrician-
sonologists are san a sizable number of obstetrics patients, they have lesser exposure when it comes to
diagnosing and managing complex gynecologic conditions such as endometriosis.

Established by Monaliza Salian and Vasant Salian in 2009 along with a partnership with Ayala Healthcare
Holdings in 2019 under the Salian Group of Companies, MedEthix Incorporated is a Philippine-based
pharmaceutical importation and distribution firm whose mission is to contribute to the nation’s goal of
attaining universal healthcare by providing Filipinos better access to affordable healthcare products and
more humane solutions – to heal always and in all ways.

MedEthix spearheaded the MEM alongside Dr. Nelinda Catherine P. Pangilinan, a renowned sonologist,
to help Filipinos in this plight. The program aims to train sonologists through didactics on the
management and diagnosis of endometriosis, capped by actual patient diagnosis and outpatient
management. The training also integrates real patient cases, ensuring participants gain practical insights
beyond textbooks and journals.

The program’s faculty is composed of esteemed consultants from the RMC Department of Obstetrics and
Gynecology and its Section of Ultrasound in Obstetrics and Gynecology. Under the leadership of Dr.
Pangilinan, the current chair of the Ultrasound Committee of the Asia and Oceania Federation of
Obstetrics and Gynecology (AOFOG), and supported by two other former presidents of the Philippine Society for Ultrasound in Obstetrics and Gynecology (PSUOG), the section is highly regarded as one of
the most respected in the Philippines.

Held twice a year, MedEthix offers an intensive two-day CME program. 16 doctors and 16 patients are
selected for each session, combining hands-on training with real-time diagnosis and treatment. Delegates
are strategically chosen nationwide, focusing on underserved areas where medical services are most
needed. By incorporating actual patient cases, the MEM brings learning to life, going beyond theoretical
knowledge on the disease.

The MedEthix Endometriosis Masterclass continues to expand its reach, providing early diagnosis and
treatment for more patients. MedEthix envisions covering the entire PSUOG membership, which currently
stands at over 600 members, to ensure improved quality of life for endometriosis patients nationwide.
Through this innovative and meaningful program by MedEthix, Filipino endometriosis patients are one
step closer to achieving wellness and fulfilling their full potential.

To learn more about MedEthix, please visit https://www.medethix.com.ph/.